(3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cryan, JF; Froestl, W; Kaupmann, K; Mombereau, C; Sansig, G; van der Putten, H | 1 |
1 other study(ies) available for (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid and Disease Models, Animal
Article | Year |
---|---|
Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Benzoates; Cyclopentanes; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; GABA-B Receptor Antagonists; Hindlimb Suspension; Male; Maze Learning; Mice; Mice, Inbred BALB C; Mice, Knockout; Motor Activity; Phosphinic Acids; Psychomotor Performance; Pyrimidines; Reaction Time; Receptors, GABA-B; Swimming | 2004 |